Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

bioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY

Author: Benzinga Newsdesk | April 02, 2024 07:59am
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company reported $2.21 million in sales this quarter. This is a 5.67 percent decrease over sales of $2.35 million the same period last year.

Posted In: BIAF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist